AI Startups

    Helical raises $10M to bridge the gap between foundation models and drug discovery decisions

    Helical secures $10 million to transform biological foundation models into reliable drug discovery workflows.

    Pharma artificial intelligence startup Helical Ltd. announced today that it has raised $10 million in new funding to expand its virtual AI lab platform, which turns biological foundation models into reproducible in-silico drug discovery workflows. Founded in 2024, Helical was bui...

    S

    SiliconANGLE

    Source

    Helical raises $10M to bridge the gap between foundation models and drug discovery decisions
    AI Analysis

    Generated insight by OnAirToday AI

    Helical is addressing the critical translation gap between raw generative biological models and actionable, reproducible pharmaceutical research. By standardizing in-silico workflows, the startup accelerates the path from predictive data to reliable drug discovery outcomes.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at SiliconANGLE →
    Share
    Filed under:AI Startups

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000